Shares Investor Evening (Manchester)
Amryt Pharma (AMYT) - a revenue-generating orphan drug company focused on acquiring, developing and commercialising products that help improve the lives of patients
Belvoir Group - (BLV) - Belvoir Group is uniquely positioned within the property sector, benefiting from the agility of a franchise business model compared with the larger corporate players, whilst providing our networks with the Central Office systems and support, not available to the smaller independent agents
Open Orphan (ORPH) - a European-focussed, rare and orphan drug consulting services platform. The Company will target the fragmented orphan drug services market in Europe
ReNeuron Group - (RENE) - ReNeuron Group is a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
SkinBioTherapeutics - (SBTX) - SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.The business strategy is to partner and outlicense its programmes at proof of concept.
VolitionRx – (VNRX) - VolitionRx is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present.
Who Should Attend
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.